At a glance

ClinicalIndex Comparison Record

Phase 3Completed

Drug / intervention

defibrillators, implantabledevice

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000540

NCT00000540Phase 3Completed

Compare CT.gov

Coronary Artery Bypass Graft (CABG) Patch Trial

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Nov 7, 2016

In Brief

A Phase 3 clinical trial evaluating defibrillators, implantable for Arrhythmia and 7 related conditions. Completed.

Detailed Summary

To test the hypothesis that implantable cardioverter defibrillator (ICD) therapy will improve survival in coronary heart disease patients at high risk of death, especially arrhythmic death.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsArrhythmia, Cardiovascular Diseases, Coronary Disease, Death, Sudden, Cardiac, Heart Diseases, Myocardial Infarction, Myocardial Ischemia, Ventricular Arrhythmia

Countries--

Collaborators--

Timeline

Phase 3CompletedFinished

199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartDec 1992

Study CompletionDec 1998

First PostedOct 1999

TodayJul 2026

First PostedOct 28, 1999

Enrollment StartDec 1, 1992

Study CompletionDec 1, 1998

TodayJul 2, 2026

Posted 26.7 years ago

Interventions

defibrillators, implantabledevice